Comment on ‘Performance of <scp>FIB</scp> ‐4 for Fibrosis Assessment in <scp>CHB</scp> – <scp>MASLD</scp> Patients’

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Authors

Institutions

Publication Details

Journal
Journal of Viral Hepatitis
Published
2025-11-29
DOI
https://doi.org/10.1111/jvh.70113
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comment on ‘Performance of FIB ‐4 for Fibrosis Assessment in CHB – MASLD Patients’

Özgür Sirkeci
Journal of Viral Hepatitis
Lung Cancer Treatments and Mutations
article

Comment on ‘Performance of FIB ‐4 for Fibrosis Assessment in CHB – MASLD Patients’

Özgür Sirkeci
article en

Abstract

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Journal of Viral HepatitisVol. 33(1)
Isparta University of Applied Sciences (TR)
Openalex Percentile: Top 44%
Lung Cancer Treatments and Mutations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Comment on ‘Performance of <scp>FIB</scp> ‐4 for Fibrosis Assessment in <scp>CHB</scp> – <scp>MASLD</scp> Patients’ — Özgür Sirkeci · Journal of Viral Hepatitis (2025) | TGRS Research Map | TGRS